NASDAQ: MXCT
Maxcyte Inc Stock Ownership - Who owns Maxcyte?

Insider buying vs selling

Have Maxcyte Inc insiders been buying or selling?

Buy
Sell
NameRoleDateSharesPriceValue
William W. BrookeDirector2025-08-1350,000$1.29
$64.50kBuy
Richard DouglasDirector2025-08-1380,000$1.39
$111.04kBuy
Stanley C. ErckDirector2025-08-13100,000$1.37
$137.20kBuy
Maher MasoudPresident and CEO2025-08-1375,000$1.37
$102.90kBuy
Douglas J. SwirskyCHIEF FINANCIAL OFFICER2025-08-1350,000$1.29
$64.50kBuy
Ali SoleymannezhadChief Commercial Officer2025-03-181,211$3.18
$3.85kSell
Douglas J. SwirskyCHIEF FINANCIAL OFFICER2025-03-186,939$3.18
$22.06kSell
David I. SandovalGENERAL COUNSEL2025-03-18353$3.18
$1.12kSell
John Joseph JohnstonDirector2025-01-273,000$4.65
$13.93kSell
John Joseph JohnstonDirector2025-01-273,000$2.93
$8.80kBuy

1 of 4

MXCT insiders have bought more... subscribe to Premium to read more.
Net Insider Buy/Sell (L12M) Ownership

Be the first to know when MXCT insiders and whales buy or sell their stock.

MXCT Shareholders

What type of owners hold Maxcyte Inc stock?

Institutional
Insider
Retail
NameHoldSharesValueType
Blackrock Inc9.57%10,202,243$14.08MInstitution
Casdin Partners Master Fund LP9.38%10,000,000$13.80MInsider
Mirabella Financial Services LLP6.19%6,600,000$9.11MInstitution
Vanguard Group Inc5.25%5,601,680$7.73MInstitution
Vitruvian Partners LLP4.73%5,043,356$6.96MInstitution
Geode Capital Management LLC2.33%2,480,488$3.42MInstitution
Dimensional Fund Advisors LP1.64%1,744,702$2.41MInstitution
Chevy Chase Trust Holdings LLC1.62%1,723,239$2.38MInstitution
Northern Trust Corp0.74%785,844$1.08MInstitution
Renaissance Technologies LLC0.67%717,800$990.56kInstitution

1 of 3

MXCT vs Medical Device Stocks

TickerInst. %Insider %Net Insider (L12M)Net Insider (L3M)
MXCT37.72%11.85%Net BuyingNet Buying
ARAY41.71%39.48%Net SellingNet Selling
LNSR30.41%51.31%Net Buying
RCEL18.28%3.83%Net BuyingNet Buying
ELMD23.00%77.00%Net Selling

Maxcyte Stock Ownership FAQ

Who owns Maxcyte?

Maxcyte (NASDAQ: MXCT) is owned by 37.72% institutional shareholders, 11.85% Maxcyte insiders, and 50.43% retail investors. Casdin Partners Master Fund LP is the largest individual Maxcyte shareholder, owning 10.00M shares representing 9.38% of the company. Casdin Partners Master Fund LP's Maxcyte shares are currently valued at $14.10M.

If you're new to stock investing, here's how to buy Maxcyte stock.
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.